Quisovalimab
| Catalog Number | Pack Size | List Price* | Quantity | |
|---|---|---|---|---|
| HY-P99810-1MG | 1 mg | 393,00 | Add | |
| HY-P99810-5MG | 5 mg | 1'001,00 | Add | |
| HY-P99810-10MG | 10 mg | 1'597,00 | Add |
* CHF, excl. 8.1% VAT and shipping costs
Product Description
Best price guarantee – we offer you the lowest price in Switzerland. Please contact us for a quote if needed.
Quisovalimab (AVTX-002; AEVI 002; SAR 252067) is a human monoclonal antibody against LIGHT, a tumor necrosis factor (TNF)-related cytokine (TNFSF14) that plays an important role in acute respiratory distress syndrome (ARDS) and cytokine release syndrome (CRS) COVID-19. Quisovalimab can be used in COVID-19 acute respiratory distress syndrome and other studies[1].
| Category | Antibody |
| Supplier | MedChem Express |
| Regulatory Status | RUO |
| Research Field | Cardiovascular Disease, Anti-infection |
| Format | Solubility: 10 mM in DMSO |
| Grade | Clinical information: Phase 2 |
| CAS-Number | 2427667-03-4 |
| Disclaimer | Shipped on dry ice - extra freight charge will occur |
| Product Line | Biosimilar |
| Tech. Data Sheet | View datasheet |
| Link To Supplier | http://www.medchemexpress.com |
| Shipping Details | Dry Ice |
| Material Safety Data Sheet | Download PDF |
